Publication | Closed Access

Development of a Recombinant Monospecific Anti-PLGF Bivalent Nanobody and Evaluation of it in Angiogenesis Modulation

Tissue EngineeringNanomedicineRegenerative MedicineVascular Tissue EngineeringNanotherapeuticsAngiogenesisEngineeringAngiogenesis ModulationFibroblast Growth FactorVascular BiologyBiomedical EngineeringNeovascularizationMedicineRadiation Oncology